CareDx Says Judge Has Issued Report Recommending US District Court In Delaware Reject Natera's Motion To Dismiss Co.'s False Advertising Complaint

CareDx, Inc. (NASDAQ:CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and

Benzinga · 01/08/2020 12:09

CareDx, Inc. (NASDAQ:CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced that on December 20, 2019, Magistrate Judge Christopher Burke issued a report recommending that the U.S. District Court for the District of Delaware reject Natera Inc.'s motion to dismiss CareDx's false advertising complaint.